NEOGEN CHEMICALS profit and loss

Latest FY26

Revenue: ₹862cr+10.9% on FY25
EBITDA: ₹138cr+0.9% on FY25
Net profit: ₹28.8cr−17.5% on FY25
EPS: ₹10.90−17.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	926	862	778	691	686	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	8.8	6.1	4.0	7.5	4.5
	934	868	782	698	691
	690	638	506	475	485
	0.7	0.0	0.0	0.0	0.0
	−192	−172	−83.0	−92.1	−96.8
	95.8	90.1	64.8	62.0	46.8
	83.3	75.1	48.5	42.1	28.9
	29.9	27.5	27.8	22.9	16.2
	177	168	153	136	139
	885	827	718	646	620
	154	138	136	110	112
	124	110	109	87.2	95.4
Profit
	49.6	41.1	64.0	52.6	70.9
	0.0	0.0	−14.1	0.0	0.0
	49.6	41.1	50.0	52.6	70.9
	19.0	17.7	19.9	12.2	12.8
	−4.5	−5.4	−4.6	4.9	8.3
	14.5	12.3	15.3	17.1	21.1
	0.4	0.0	0.2	0.2	0.1
	35.6	28.8	34.8	35.7	50.0
	35.2	28.8	34.6	35.5	49.9
	1.0	0.8	−0.4	−0.6	0.3
	36.6	29.5	34.4	35.1	50.3
	—	—	—	—	50.0
Per share
	₹13.29	₹10.90	₹13.20	₹13.96	₹20.03
	₹13.29	₹10.90	₹13.20	₹13.96	₹20.03
Revenue detail — as filed
	—	0.0	0.0	0.2	0.1
Other comprehensive income — detail
	1.0	0.8	−0.4	—	—
	1.4	1.0	−0.6	−0.8	0.4
	0.3	0.2	−0.1	—	—
	—	—	—	−0.2	0.1
	—	—	—	—	50.0
Per share — as-filed variants
	₹13.29	₹10.90	₹13.20	₹13.96	₹20.03
	₹13.29	₹10.90	₹13.20	₹13.96	₹20.03
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	427	396	355	308	298
	46.1%	45.9%	45.6%	44.6%	43.4%
Adjusted (ex-exceptional items) — derived
	49.6	41.1	64.0	52.6	70.9
	0.0	0.0	−14.1	0.0	0.0
	35.6	28.8	44.6	35.7	50.0
	₹13.29	₹10.90	₹16.90	₹13.96	₹20.03

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEOGEN₹2,261.70

NEOGEN CHEMICALS LTD.

· Chemicals

Annual Quarterly₹ CrorePeersTATACHEM AETHER NFL LXCHEM PRIVISCL RAIN RALLIS RCFMcap ₹5,966 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	686.2	690.7	777.6	862.0	925.5
Other Income	4.5	7.5	4.0	6.1	8.8
Total Income	690.6	698.1	781.6	868.1	934.4
Expenses
+ Cost of Materials Consumed	485.3	474.6	506.1	638.1	689.8
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.7
+ Changes in Inventories	-96.8	-92.1	-83.0	-171.6	-192.0
+ Employee Benefit Expense	46.8	62.0	64.8	90.1	95.8
+ Finance Costs	28.9	42.1	48.5	75.1	83.3
+ Depreciation & Amortisation	16.2	22.9	27.8	27.5	29.9
+ Other Expenses	139.2	136.1	153.3	167.9	177.2
Total Expenses	619.7	645.6	717.5	827.0	884.7
EBITDA	111.6	110.1	136.3	137.6	154.0
EBIT	95.4	87.2	108.5	110.1	124.1
Profit
PBT before Exceptional Items	70.9	52.6	64.0	41.1	49.6
+ Exceptional Items	0.0	0.0	-14.1	0.0	0.0
Pretax Income	70.9	52.6	50.0	41.1	49.6
+ Current Tax	12.8	12.2	19.9	17.7	19.0
+ Deferred Tax	8.3	4.9	-4.6	-5.4	-4.5
Tax Expense	21.1	17.1	15.3	12.3	14.5
+ Share of Associates & JVs	0.1	0.2	0.2	0.0	0.4
Net Income	50.0	35.7	34.8	28.8	35.6
+ Net Income — Continuing Ops	49.9	35.5	34.6	28.8	35.2
+ Other Comprehensive Income	0.3	-0.6	-0.4	0.8	1.0
Total Comprehensive Income	50.3	35.1	34.4	29.5	36.6
Net Income to Common	50.0	—	—	—	—
Per Share
Basic EPS	20.03	13.96	13.20	10.90	13.29
Diluted EPS	20.03	13.96	13.20	10.90	13.29
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	0.1	0.2	0.0	0.0	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.4	0.8	1.0
+ Items NOT to be Reclassified to P&L	0.4	-0.8	-0.6	1.0	1.4
+ Tax on Items NOT to be Reclassified	—	—	-0.1	0.2	0.3
+ Tax on Items NOT to be Reclassified — alt tag	0.1	-0.2	—	—	—
Comprehensive Income — Owners of Parent	50.0	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	20.03	13.96	13.20	10.90	13.29
Diluted EPS — Continuing Operations	20.03	13.96	13.20	10.90	13.29
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	297.7	308.2	354.5	395.5	427.0
Gross Margin %	43.38	44.62	45.59	45.88	46.14
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	70.9	52.6	64.0	41.1	49.6
− Exceptional Items (reconciliation)	0.0	0.0	-14.1	0.0	0.0
Net Income Adj (tax-effected)	50.0	35.7	44.6	28.8	35.6
EPS Adj	20.03	13.96	16.90	10.90	13.29
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	24.9	26.4	26.4	26.4	27.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.